Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
News|Articles|November 2, 2020
Quality of Life Factors in Behçet Disease
Author(s)Leo Robert
In Behçet disease, disease activity and manifestations can significantly impact quality of life; lifestyle choices also play a role. We highlight 8 studies to help illustrate.
Advertisement
The disease activity and manifestations of Behçet disease (BD) may have a considerable impact on patients’ quality of life.
The onset, disease course, and the severity of inflammation in patients with BD may be influenced by a variety of lifestyle factors.
Scroll through the slides below for 8 concise descriptions of research on key quality of life factors in BD.
Advertisement
Related to this article
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
Advertisement
Advertisement